Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

被引：215

作者：

Tefferi, A. ^{[1
]}

Lim, K-H ^{[1
,2
,3
]}

Abdel-Wahab, O. ^{[4
,5
]}

Lasho, T. L. ^{[1
]}

Patel, J. ^{[4
]}

Patnaik, M. M. ^{[1
]}

Hanson, C. A. ^{[1
,2
]}

Pardanani, A. ^{[1
]}

Gilliland, D. G. ^{[6
,7
]}

Levine, R. L. ^{[4
,5
]}

机构：

[1] Mayo Clin & Mayo Fdn, Dept Med, Div Hematol & Hematopathol, Rochester, MN 55905 USA

[2] Mayo Clin, Div Hematopathol, Rochester, MN USA

[3] Mackay Mem Hosp & Mackay Med, Div Hematol Oncol, Nursing & Management Coll, Taipei, Taiwan

[4] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA

[6] Harvard Univ, Brigham & Womens Hosp, Div Hematol, Dept Med,Dana Farber Canc Inst,Med Sch, Boston, MA 02115 USA

[7] Howard Hughes Med Inst, Boston, MA 02115 USA

来源：

LEUKEMIA | 2009年 / 23卷 / 07期

关键词：

D O I：

10.1038/leu.2009.59

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1343 / 1345

页数：4

共 6 条

[1]

DELHOMMEAU F, 2008, ASH ANN M, V112

[2]

Jaffe E S., 2001, World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissues, P1

[3] Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival [J].

Tefferi, A. ;

Lasho, T. L. ;

Huang, J. ;

Finke, C. ;

Mesa, R. A. ;

Li, C. Y. ;

Wu, W. ;

Hanson, C. A. ;

Pardanani, A. .

LEUKEMIA, 2008, 22 (04) :756-761

[4] Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms [J].

Tefferi, A. ;

Vardiman, J. W. .

LEUKEMIA, 2008, 22 (01) :14-22

[5] TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis [J].

Tefferi, A. ;

Pardanani, A. ;

Lim, K-H ;

Abdel-Wahab, O. ;

Lasho, T. L. ;

Patel, J. ;

Gangat, N. ;

Finke, C. M. ;

Schwager, S. ;

Mullally, A. ;

Li, C-Y ;

Hanson, C. A. ;

Mesa, R. ;

Bernard, O. ;

Delhommeau, F. ;

Vainchenker, W. ;

Gilliland, D. G. ;

Levine, R. L. .

LEUKEMIA, 2009, 23 (05) :905-911

[6] Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates [J].

Tefferi, A. ;

Levine, R. L. ;

Lim, K-H ;

Abdel-Wahab, O. ;

Lasho, T. L. ;

Patel, J. ;

Finke, C. M. ;

Mullally, A. ;

Li, C-Y ;

Pardanani, A. ;

Gilliland, D. G. .

LEUKEMIA, 2009, 23 (05) :900-904

← 1 →